Qiang Fu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Qiang Fu has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Guizhi Zhang
Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, PR China
2 shared publications - Jian Tan
Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, PR China
2 shared publications - Jianping Zhang
Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, PR China
2 shared publications - Ke Xu
Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, China
2 shared publications - Li Xue
Affiliation Department of Urology, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
2 shared publications - Qiang Jia
Shandong Academy of Occupational Health and Occupational Medicine, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, 250062, China
2 shared publications
Latest Publications
- Open Access
- 23 December 2019
- Published by Impact Journals, LLC in Aging
- Vol. 11 (24) , 11865-11879
MicroRNA 27b promotes cardiac fibrosis by targeting the FBW7/Snail pathway
Our study aspires to understand the impact of miR-27b on myocardial fibrosis as well as its functional mechanism. 12 days post the ligation of coronary artery in rats, the expression of miR-27b in the peri-infarction region was elevated. Treating cultivated rat neonatal cardiac fibroblasts (CFs) with angiotensin II (AngII) also enhanced the miR-27b expression. Forced expression of miR-27b promoted the proliferation and collagen production in rat neonatal CFs, as revealed by cell counting, MTT assay, and quantitative reverse transcription-polymerase chain reaction. FBW7 was found to be the miR-27b's target since the overexpression of miR-27b reduced the transcriptional level of FBW7. The enhanced expression of FBW7 protein abrogated the effects of miR-27b in cultured CFs, while the siRNA silence of FBW7 promoted the pro-fibrosis activity of AngII. As to the mechanism, we found that the expression of FBW7 led to the degradation of Snail, which is an important regulator of cardiac epithelial-mesenchymal transitions. Importantly, inhibition of miR-27b abrogated the coronary artery ligation (CAL) induced cardiac fibrosis in vivo, suggesting that it might be a potential target for the treatment of fibrosis associated cardiac diseases.
- 23 December 2019
- Published by Impact Journals, LLC in Aging
- Vol. 11 (24) , 11865-11879
Open AccessMicroRNA 27b promotes cardiac fibrosis by targeting the FBW7/Snail pathway
Our study aspires to understand the impact of miR-27b on myocardial fibrosis as well as its functional mechanism. 12 days post the ligation of coronary artery in rats, the expression of miR-27b in the peri-infarction region was elevated. Treating cultivated rat neonatal cardiac fibroblasts (CFs) with angiotensin II (AngII) also enhanced the miR-27b expression. Forced expression of miR-27b promoted the proliferation and collagen production in rat neonatal CFs, as revealed by cell counting, MTT assay, and quantitative reverse transcription-polymerase chain reaction. FBW7 was found to be the miR-27b's target since the overexpression of miR-27b reduced the transcriptional level of FBW7. The enhanced expression of FBW7 protein abrogated the effects of miR-27b in cultured CFs, while the siRNA silence of FBW7 promoted the pro-fibrosis activity of AngII. As to the mechanism, we found that the expression of FBW7 led to the degradation of Snail, which is an important regulator of cardiac epithelial-mesenchymal transitions. Importantly, inhibition of miR-27b abrogated the coronary artery ligation (CAL) induced cardiac fibrosis in vivo, suggesting that it might be a potential target for the treatment of fibrosis associated cardiac diseases.
- Open Access
- 1 October 2016
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Pharmacology
- Vol. 11 (4) , 863-868
Lapatinib, trastuzumab or the combination added to neoadjuvant chemotherapy for breast cancer
The aim of this study was to compare the efficacy and safety of trastuzumab versus the combination of trastuzumab and lapatinib added to neoadjuvant chemotherapy for HER2 positive breast cancer. PubMed, MEDLINE, The Cochrane Library, Web of Science and nearly 5 years of the important international conference on oncology records were searched for randomized clinical trials that compared lapatinib plus trastuzumab and neoadjuvant chemotherapy (NAC) with trastuzumab in combination with NAC and that included pathologic complete response rate as the primary outcome. Finally, 6 clinical randomized controlled trials were included. Meta-analysis shows that pathological complete response rate was significantly increased in trastu-zumab plus lapatinib group than single use trastuzumab group (53.4%, 40.4%, RR = 1.75, 95% CI 1.38 ~ 2.23, p<0.001). In conclusion, the combination of trastuzumab and lapatinib added to neoadjuvant chemotherapy in HER2 positive breast cancer is more effective.
- 1 October 2016
- Published by Bangladesh Academy of Sciences in Bangladesh Journal of Pharmacology
- Vol. 11 (4) , 863-868
Open AccessLapatinib, trastuzumab or the combination added to neoadjuvant chemotherapy for breast cancer
The aim of this study was to compare the efficacy and safety of trastuzumab versus the combination of trastuzumab and lapatinib added to neoadjuvant chemotherapy for HER2 positive breast cancer. PubMed, MEDLINE, The Cochrane Library, Web of Science and nearly 5 years of the important international conference on oncology records were searched for randomized clinical trials that compared lapatinib plus trastuzumab and neoadjuvant chemotherapy (NAC) with trastuzumab in combination with NAC and that included pathologic complete response rate as the primary outcome. Finally, 6 clinical randomized controlled trials were included. Meta-analysis shows that pathological complete response rate was significantly increased in trastu-zumab plus lapatinib group than single use trastuzumab group (53.4%, 40.4%, RR = 1.75, 95% CI 1.38 ~ 2.23, p<0.001). In conclusion, the combination of trastuzumab and lapatinib added to neoadjuvant chemotherapy in HER2 positive breast cancer is more effective.
- Open Access
- 1 January 2016
- Published by Walter de Gruyter GmbH in Open Life Sciences
- Vol. 11 (1) , 98-104
Advancement of Wnt signal pathway and the target of breast cancer
Wnt/β-catenin signaling has been proved to play an important role in the development and promotion of cancer metastasis. The activation of Wnt signals can lead to duplicating, updating, metastasizing and relapsing. The Wnt signaling pathway is mainly divided into the Wnt/β-catenin pathway and the Wnt/calcium pathway. A better understanding of all the diverse functions of Wnt and their molecular mechanisms has evoked prevailing interest in identifying additional targets related to the Wnt /β-catenin pathways in breast cancer. A number of new target, related to Wnt /β-catenin pathways have been identified in recent years, including NOP14, BKCa channels, Emilin2, WISP, MicroRNAs, NRBP1, TRAF4, and Wntless. In this review, we will introduce the new targets related to the Wnt /β-catenin pathways in breast cancer
- 1 January 2016
- Published by Walter de Gruyter GmbH in Open Life Sciences
- Vol. 11 (1) , 98-104
Open AccessAdvancement of Wnt signal pathway and the target of breast cancer
Wnt/β-catenin signaling has been proved to play an important role in the development and promotion of cancer metastasis. The activation of Wnt signals can lead to duplicating, updating, metastasizing and relapsing. The Wnt signaling pathway is mainly divided into the Wnt/β-catenin pathway and the Wnt/calcium pathway. A better understanding of all the diverse functions of Wnt and their molecular mechanisms has evoked prevailing interest in identifying additional targets related to the Wnt /β-catenin pathways in breast cancer. A number of new target, related to Wnt /β-catenin pathways have been identified in recent years, including NOP14, BKCa channels, Emilin2, WISP, MicroRNAs, NRBP1, TRAF4, and Wntless. In this review, we will introduce the new targets related to the Wnt /β-catenin pathways in breast cancer
- 1 June 2015
- Published by Elsevier in Life Sciences
- Vol. 130, 18-24
Evaluation of serum midkine as a biomarker in differentiated thyroid cancer
- 1 June 2015
- Published by Elsevier in Life Sciences
- Vol. 130, 18-24
Evaluation of serum midkine as a biomarker in differentiated thyroid cancer
- 1 November 2014
- Published by Elsevier in Life Sciences
- Vol. 118 (1) , 39-45
Immunohistochemical evaluation of midkine and nuclear factor-kappa B as diagnostic biomarkers for papillary thyroid cancer and synchronous metastasis
- 1 November 2014
- Published by Elsevier in Life Sciences
- Vol. 118 (1) , 39-45
Immunohistochemical evaluation of midkine and nuclear factor-kappa B as diagnostic biomarkers for papillary thyroid cancer and synchronous metastasis
- 1 January 2014
- Vol. 127 (8) , 1497-503
Clinical outcome of ileal pouch-anal anastomosis for chronic ulcerative colitis in China.
The incidence of chronic ulcerative colitis (CUC) in China is remarkably increasing, while little information on surgical treatment has been reported. This study aimed to completely describe and analyze the clinical outcome of restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) for CUC in China. Ninety-five consecutive patients, who suffered CUC and had surgical indications, were carefully selected. All patients underwent IPAA. Data on patient characteristics, surgical indications, surgical details, postoperative complications, functional outcome, and quality of life were collected. The mean patient age at the time of the operation was 32 years. Twenty-nine (31%) patients underwent an emergency operation, and 66 (69%) underwent elective procedures. Four patients with severe dysplasia underwent operations, but no carcinoma was histologically confirmed. A two-stage operation was performed in 87 (92%) patients, and a hand-sewn technique was applied in 88 (93%) patients. Sixteen patients (17.0%) experienced early complications, and there was a significant difference between the emergency surgery group and the elective group (31.0% vs. 10.6%, respectively; P < 0.01). Five (5.3%) patients developed pouchitis as a late complication. The mean stool frequency after the operation was 4.6 (2-11) during the first 24 hours and 1.5 (0-4) overnight. According to the Kirwan grading scale, 87 (91.8%) patients showed satisfactory anal continence function. The quality of life improved significantly from a preoperative mean value of 0.28-0.61 before ileostomy closure to 0.78 after ileostomy closure (P < 0.01) according to the Cleveland Global Quality of Life index. IPAA is an effective and safe surgical procedure for patients with CUC in China. However, some characteristics, such as the low incidence of pouchitis, require further study.
- 1 January 2014
- Vol. 127 (8) , 1497-503
Clinical outcome of ileal pouch-anal anastomosis for chronic ulcerative colitis in China.
The incidence of chronic ulcerative colitis (CUC) in China is remarkably increasing, while little information on surgical treatment has been reported. This study aimed to completely describe and analyze the clinical outcome of restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) for CUC in China. Ninety-five consecutive patients, who suffered CUC and had surgical indications, were carefully selected. All patients underwent IPAA. Data on patient characteristics, surgical indications, surgical details, postoperative complications, functional outcome, and quality of life were collected. The mean patient age at the time of the operation was 32 years. Twenty-nine (31%) patients underwent an emergency operation, and 66 (69%) underwent elective procedures. Four patients with severe dysplasia underwent operations, but no carcinoma was histologically confirmed. A two-stage operation was performed in 87 (92%) patients, and a hand-sewn technique was applied in 88 (93%) patients. Sixteen patients (17.0%) experienced early complications, and there was a significant difference between the emergency surgery group and the elective group (31.0% vs. 10.6%, respectively; P < 0.01). Five (5.3%) patients developed pouchitis as a late complication. The mean stool frequency after the operation was 4.6 (2-11) during the first 24 hours and 1.5 (0-4) overnight. According to the Kirwan grading scale, 87 (91.8%) patients showed satisfactory anal continence function. The quality of life improved significantly from a preoperative mean value of 0.28-0.61 before ileostomy closure to 0.78 after ileostomy closure (P < 0.01) according to the Cleveland Global Quality of Life index. IPAA is an effective and safe surgical procedure for patients with CUC in China. However, some characteristics, such as the low incidence of pouchitis, require further study.
- Open Access
- 1 January 2005
- Published by Acta Physica Sinica, Chinese Physical Society and Institute of Physics, Chinese Academy of Sciences in Acta Physica Sinica
- Vol. 54 (10) , 4633-4637
Optical absorption, Raman spectra and TEM study of Ag nanoparticles formed by ion implantation into a-SiO2
能量为200keV的Ag离子,以1×1016,5×1016,1×1017 cm-2的剂量分别注入到非晶SiO2玻璃,光学吸收谱显示:注入剂量为1×1016 cm-2的样品的光吸收谱为洛伦兹曲线,与Mie理论模拟的曲线形状一致;注入剂量较大的5×1016,1×1017 cm-2的谱线共振吸收增强,峰位红移并出现伴峰. 透射电镜观察分析表明,注入剂量不同的样品中形成的纳米颗粒的大小、形状、分布都不同,注入剂量较大的还会产生明显的表面溅射效应,这些因素都会影响共振吸收的峰形、峰位和峰强. 当注入剂量达到1×1017 cm-2时,Ag纳米颗粒内部可能还形成了杂质团簇.
- 1 January 2005
- Published by Acta Physica Sinica, Chinese Physical Society and Institute of Physics, Chinese Academy of Sciences in Acta Physica Sinica
- Vol. 54 (10) , 4633-4637
Open AccessOptical absorption, Raman spectra and TEM study of Ag nanoparticles formed by ion implantation into a-SiO2
能量为200keV的Ag离子,以1×1016,5×1016,1×1017 cm-2的剂量分别注入到非晶SiO2玻璃,光学吸收谱显示:注入剂量为1×1016 cm-2的样品的光吸收谱为洛伦兹曲线,与Mie理论模拟的曲线形状一致;注入剂量较大的5×1016,1×1017 cm-2的谱线共振吸收增强,峰位红移并出现伴峰. 透射电镜观察分析表明,注入剂量不同的样品中形成的纳米颗粒的大小、形状、分布都不同,注入剂量较大的还会产生明显的表面溅射效应,这些因素都会影响共振吸收的峰形、峰位和峰强. 当注入剂量达到1×1017 cm-2时,Ag纳米颗粒内部可能还形成了杂质团簇.